NDA 020678 · Baxter Hlthcare
Clinimix E 5/20 Sulfite Free W/ Elect In 20% Dextrose W/ Calcium In Plastic Container
Amino Acids, Calcium Chloride, Dextrose, Magnesium Chloride, Potassium Phosphate, Dibasic, Sodium Acetate, Sodium Chloride · Injection · Amino Acid
Last checked: Nov 20, 2026Latest source record: Apr 13, 2021 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1997
Mar 26, 1997
Approved uses
2
Original approval plus efficacy supplements
Registered trials
30,323
6,603 Phase 3, 2,682 recruiting
FAERS reports
79
47 serious, 11 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Apr 13, 2021.
CLINIMIX E is indicated as a source of calories, protein, and electrolytes for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. CLINIMIX E may be used to treat negative nitrogen balance in patients. CLINIMIX E is indicated as a source of calories, protein, and electrolytes for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. CLINIMIX E may be used to treat negative nitrogen balance in patients. ( 1 )
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Apr 12, 2000 Supplement 3 · Efficacy ReviewLetter
- Mar 26, 1997 Original approval · Type 4 - New Combination Review
12 products under this application
- CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 5%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 20GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 340MG/100ML; SODIUM CHLORIDE 59MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 5/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 5%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 10GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 340MG/100ML; SODIUM CHLORIDE 59MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 4.25/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 4.25%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 5GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 297MG/100ML; SODIUM CHLORIDE 77MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 4.25/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 4.25%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 25GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 297MG/100ML; SODIUM CHLORIDE 77MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 2.75%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 10GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 217MG/100ML; SODIUM CHLORIDE 112MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 5/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 5%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 25GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 340MG/100ML; SODIUM CHLORIDE 59MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 5/15 SULFITE FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 5%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 15GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 340MG/100ML; SODIUM CHLORIDE 59MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 4.25/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 4.25%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 10GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 297MG/100ML; SODIUM CHLORIDE 77MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 5/35 SULFITE FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 5%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 35GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 340MG/100ML; SODIUM CHLORIDE 59MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 2.75%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 25GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 217MG/100ML; SODIUM CHLORIDE 112MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 4.25/20 SULFITE FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 4.25%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 20GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 297MG/100ML; SODIUM CHLORIDE 77MG/100ML · INJECTABLE, INJECTION · Prescription
- CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER · AMINO ACIDS 2.75%; CALCIUM CHLORIDE 33MG/100ML; DEXTROSE 5GM/100ML; MAGNESIUM CHLORIDE 51MG/100ML; POTASSIUM PHOSPHATE, DIBASIC 261MG/100ML; SODIUM ACETATE 217MG/100ML; SODIUM CHLORIDE 112MG/100ML · INJECTABLE, INJECTION · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Amino Acids" as an intervention, any sponsor and status, largest first.
- Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 YearsPivotal-lookingNot yet recruiting
Tor Biering-SørensenAcademic, hospital or other
NCT07790523 · 410,000 participants (planned) · Start Sep 1, 2026 · Primary completion May 31, 2028
Drug: mCombriax® (mRNA-1083); Efluelda® (TIV-HD) and Spikevax® (mRNA-1273) · For: COVID-19; Influenza
Sites: Hellerup, Denmark; Søborg, Denmark; Santiago de Compostela, Spain
- Community Level Interventions for Pre-eclampsiaPivotal-lookingCompleted
University of British ColumbiaAcademic, hospital or other
NCT01911494 · 87,500 participants (planned) · Start Sep 2013 · Primary completion May 2018
Drug: Magnesium Sulfate; Methyldopa · For: Pre-eclampsia; Hypertension, Pregnancy Induced
Sites: Belagavi, India; Maputo, Mozambique; Sagamu, Nigeria · 4 sites in all
- Randomised Evaluation of COVID-19 TherapyPivotal-lookingRecruiting
University of OxfordAcademic, hospital or other
NCT04381936 · 70,000 participants (planned) · Start Mar 19, 2020 · Primary completion Sep 30, 2028
Drug: Lopinavir-Ritonavir; Corticosteroid and 20 more · For: Pneumonia
Sites: Brussels, Belgium; Tallinn, Estonia; Paris, France · 16 sites in all
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated DonorsPivotal-lookingRecruiting
Center for International Blood and Marrow Transplant ResearchResearch network
NCT00785525 · 60,000 participants (planned) · Start Feb 1997 · Primary completion Jan 2030
Drug: Filgrastim · For: Healthy
Sites: Boca Raton, Florida; Rockville, Maryland; Minneapolis, Minnesota · 4 sites in all
- Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy IndividualsPivotal-lookingCompleted
BioNTech SEIndustry
NCT04368728 · 46,969 participants · Start Apr 29, 2020 · Primary completion Feb 10, 2023
Drug: BNT162b1; BNT162b2 and 1 more · For: SARS-CoV-2 Infection; COVID-19
Sites: Athens, Alabama; Birmingham, Alabama; Huntsville, Alabama · 175 sites in all
- Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19Pivotal-lookingCompleted
Tor Biering-SørensenAcademic, hospital or other
NCT07279766 · 41,060 participants · Start Dec 11, 2025 · Primary completion Aug 26, 2026
Drug: mRNA-1273 (Moderna COVID-19 vaccine) · For: COVID-19
Sites: Hellerup, Denmark; Søborg, Denmark
- Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over TrialPivotal-lookingNot yet recruiting
Hamilton Health Sciences CorporationAcademic, hospital or other
NCT06567808 · 38,000 participants (planned) · Start Mar 1, 2026 · Primary completion Apr 30, 2028
Drug: Cefazolin; Vancomycin · For: Infection, Surgical Site
- A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19Pivotal-lookingCompleted
ModernaTX, Inc.Moderna (MRNA)
NCT04470427 · 30,415 participants · Start Jul 27, 2020 · Primary completion Dec 29, 2022
Drug: mRNA-1273; Placebo · For: SARS-CoV-2
Sites: Birmingham, Alabama; Chandler, Arizona; Glendale, Arizona · 100 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- no adverse event10
- wrong technique in drug usage process9
- dyspnoea6
- nausea6
- death5
- headache4
- poor quality drug administered4
- urticaria4
- asthenia3
- blood creatinine increased3
- blood potassium increased3
- erythema3
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 11 |
| 2021 | 9 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 9 |
Recalls
5 FDA enforcement reports for this application.
Jan 21, 2016 · Class I · Terminated
Presence of Particulate Matter: identified as dried skin.
Mar 23, 2015 · Class II · Terminated
Lack of Assurance of Sterility; increased complaints received for leaks
Nov 25, 2014 · Class II · Terminated
Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal
Nov 18, 2013 · Class I · Terminated
Presence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.
Nov 18, 2013 · Class I · Terminated
Presence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis.
Chan V, Lo K · Postgrad Med J 2022 · Meta-Analysis, Systematic Review
- β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis.
Saunders B, Elliott-Sale K, Artioli GG, et al. · Br J Sports Med 2017 · Meta-Analysis, Systematic Review
- Signatures and Clinical Significance of Amino Acid Flux in Sarcopenia: A Systematic Review and Meta-Analysis.
Dai M, Lin T, Yue J, et al. · Front Endocrinol (Lausanne) 2021 · Meta-Analysis, Research Support, Non-U.S. Gov't
- Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses.
Gielen E, Beckwée D, Delaere A, et al. · Nutr Rev 2021 · Meta-Analysis, Systematic Review
- Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis.
Konstantis G, Pourzitaki C, Chourdakis M, et al. · Clin Nutr 2022 · Meta-Analysis, Systematic Review
- Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis.
Picca A, Coelho-Junior HJ, Calvani R, et al. · Ageing Res Rev 2022 · Meta-Analysis, Research Support, Non-U.S. Gov't
Sponsor: Baxter Hlthcare · Also marketed as Clinimix E 5/10 Sulfite Free W/ Elect In Dextrose 10% W/ Calcium In Plastic Container, Clinimix E 4.25/5 Sulfite Free W/ Elect In Dextrose 5% W/ Calcium In Plastic Container, Clinimix E 4.25/25 Sulfite Free W/ Elect In Dextrose 25% W/ Calcium In Plastic Container, Clinimix E 2.75/10 Sulfite Free W/ Elect In Dextrose 10% W/ Calcium In Plastic Container, Clinimix E 5/25 Sulfite Free W/ Elect In Dextrose 25% W/ Calcium In Plastic Container
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.